Our recent study identified non-APL AML blasts having an inversion of chromosome 16 and the presence of CBFB-MYH11 fusion transcripts as sensitive to ATRA in vitro40, but no such conventional diagnostic markers can be used to identify low dose AraC sensitive patients. The gene discussed is MYH11; the disease is acute myeloid leukemia.